318 related articles for article (PubMed ID: 35466050)
1. Efficacy of Diltiazem to Improve Coronary Vasomotor Dysfunction in ANOCA: The EDIT-CMD Randomized Clinical Trial.
Jansen TPJ; Konst RE; de Vos A; Paradies V; Teerenstra S; van den Oord SCH; Dimitriu-Leen A; Maas AHEM; Smits PC; Damman P; van Royen N; Elias-Smale SE
JACC Cardiovasc Imaging; 2022 Aug; 15(8):1473-1484. PubMed ID: 35466050
[TBL] [Abstract][Full Text] [Related]
2. Multivessel Coronary Function Testing Increases Diagnostic Yield in Patients With Angina and Nonobstructive Coronary Arteries.
Rehan R; Wong CCY; Weaver J; Chan W; Tremmel JA; Fearon WF; Ng MKC; Yong ASC
JACC Cardiovasc Interv; 2024 May; 17(9):1091-1102. PubMed ID: 38749588
[TBL] [Abstract][Full Text] [Related]
3. Vasomotor dysfunction in patients with angina and nonobstructive coronary artery disease is dominated by vasospasm.
Konst RE; Damman P; Pellegrini D; Hartzema-Meijer MJ; van Uden BJC; Jansen TPJ; Brandsma J; Vart P; Gehlmann H; Maas AHEM; van Royen N; Elias-Smale SE
Int J Cardiol; 2021 Jun; 333():14-20. PubMed ID: 33711394
[TBL] [Abstract][Full Text] [Related]
4. ANOCA patients with and without coronary vasomotor dysfunction present with limited electrocardiographic remodeling.
Schipaanboord DJM; Jansen TPJ; Crooijmans C; Onland-Moret NC; Elias-Smale SE; Dimitriu-Leen AC; van der Harst P; van de Hoef TP; van Es R; Damman P; den Ruijter HM;
Int J Cardiol Heart Vasc; 2024 Feb; 50():101347. PubMed ID: 38322017
[TBL] [Abstract][Full Text] [Related]
5. Coronary Vasomotor Dysfunction Is Associated With Cardiovascular Events in Patients With Nonobstructive Coronary Artery Disease.
Kanaji Y; Ahmad A; Sara JDS; Ozcan I; Akhiyat N; Prasad A; Raphael CE; Kakuta T; Lerman LO; Lerman A
JACC Cardiovasc Interv; 2024 Feb; 17(4):474-487. PubMed ID: 38418053
[TBL] [Abstract][Full Text] [Related]
6. Relation Between Coronary Tortuosity and Vasomotor Dysfunction in Patients Without Obstructed Coronaries?
Jansen TPJ; van Keeken K; Konst RE; Dimitriu-Leen A; Maas AHEM; van Royen N; Damman P; Elias-Smale S
Front Cardiovasc Med; 2021; 8():804731. PubMed ID: 35097023
[No Abstract] [Full Text] [Related]
7. Sex Differences in Coronary Function Test Results in Patient With Angina and Nonobstructive Disease.
Jansen TPJ; Elias-Smale SE; van den Oord S; Gehlmann H; Dimitiriu-Leen A; Maas AHEM; Konst RE; van Royen N; Damman P
Front Cardiovasc Med; 2021; 8():750071. PubMed ID: 34722680
[No Abstract] [Full Text] [Related]
8. Comparison of nebivolol versus diltiazem in improving coronary artery spasm and quality of life in patients with hypertension and vasospastic angina: A prospective, randomized, double-blind pilot study.
Kook H; Hong SJ; Yang KS; Lee S; Kim JS; Park CG
PLoS One; 2020; 15(9):e0239039. PubMed ID: 32915892
[TBL] [Abstract][Full Text] [Related]
9. Design and rationale of the NetherLands registry of invasive Coronary vasomotor Function Testing (NL-CFT).
Crooijmans C; Jansen TPJ; Konst RE; Woudstra J; Appelman Y; den Ruijter HM; Onland-Moret NC; Meeder JG; de Vos AMJ; Paradies V; Woudstra P; Sjauw KD; van 't Hof A; Meuwissen M; Winkler P; Boersma E; van de Hoef TP; Maas AHEM; Dimitriu-Leen AC; van Royen N; Elias-Smale SE; Damman P;
Int J Cardiol; 2023 May; 379():1-8. PubMed ID: 36863419
[TBL] [Abstract][Full Text] [Related]
10. Coronary artery spasm and impaired myocardial perfusion in patients with ANOCA: Predictors from a multimodality study using stress CMR and acetylcholine testing.
Pirozzolo G; Martínez Pereyra V; Hubert A; Guenther F; Sechtem U; Bekeredjian R; Mahrholdt H; Ong P; Seitz A
Int J Cardiol; 2021 Nov; 343():5-11. PubMed ID: 34499976
[TBL] [Abstract][Full Text] [Related]
11. Microvascular coronary artery spasm presents distinctive clinical features with endothelial dysfunction as nonobstructive coronary artery disease.
Ohba K; Sugiyama S; Sumida H; Nozaki T; Matsubara J; Matsuzawa Y; Konishi M; Akiyama E; Kurokawa H; Maeda H; Sugamura K; Nagayoshi Y; Morihisa K; Sakamoto K; Tsujita K; Yamamoto E; Yamamuro M; Kojima S; Kaikita K; Tayama S; Hokimoto S; Matsui K; Sakamoto T; Ogawa H
J Am Heart Assoc; 2012 Oct; 1(5):e002485. PubMed ID: 23316292
[TBL] [Abstract][Full Text] [Related]
12. Sex-Related Differences in Vasomotor Function in Patients With Angina and Unobstructed Coronary Arteries.
Aziz A; Hansen HS; Sechtem U; Prescott E; Ong P
J Am Coll Cardiol; 2017 Nov; 70(19):2349-2358. PubMed ID: 29096805
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Management of ANOCA, Part 1-Definition, Patient Population, and Diagnosis: JACC State-of-the-Art Review.
Samuels BA; Shah SM; Widmer RJ; Kobayashi Y; Miner SES; Taqueti VR; Jeremias A; Albadri A; Blair JA; Kearney KE; Wei J; Park K; Barseghian El-Farra A; Holoshitz N; Janaszek KB; Kesarwani M; Lerman A; Prasad M; Quesada O; Reynolds HR; Savage MP; Smilowitz NR; Sutton NR; Sweeny JM; Toleva O; Henry TD; Moses JW; Fearon WF; Tremmel JA;
J Am Coll Cardiol; 2023 Sep; 82(12):1245-1263. PubMed ID: 37704315
[TBL] [Abstract][Full Text] [Related]
14. Clinical, angiographic and echocardiographic correlates of epicardial and microvascular spasm in patients with myocardial ischaemia and non-obstructive coronary arteries.
Montone RA; Niccoli G; Russo M; Giaccari M; Del Buono MG; Meucci MC; Gurgoglione F; Vergallo R; D'Amario D; Buffon A; Leone AM; Burzotta F; Aurigemma C; Trani C; Liuzzo G; Lanza GA; Crea F
Clin Res Cardiol; 2020 Apr; 109(4):435-443. PubMed ID: 31270616
[TBL] [Abstract][Full Text] [Related]
15. [Angina and no obstruction on coronary angiography : New approaches to the diagnosis and treatment of vasomotor disorders].
Ong P; Rudolph TK; Wiebe J; Berger R; Woitek F; Landmesser U
Inn Med (Heidelb); 2024 May; 65(5):495-502. PubMed ID: 38517528
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries).
Ong P; Athanasiadis A; Borgulya G; Mahrholdt H; Kaski JC; Sechtem U
J Am Coll Cardiol; 2012 Feb; 59(7):655-62. PubMed ID: 22322081
[TBL] [Abstract][Full Text] [Related]
17. Coronary microvascular dysfunction assessed by intracoronary acetylcholine provocation testing is a frequent cause of ischemia and angina in patients with exercise-induced electrocardiographic changes and unobstructed coronary arteries.
Ong P; Athanasiadis A; Hill S; Schäufele T; Mahrholdt H; Sechtem U
Clin Cardiol; 2014 Aug; 37(8):462-7. PubMed ID: 24719338
[TBL] [Abstract][Full Text] [Related]
18. Coronary Microvascular Disease in Contemporary Clinical Practice.
Smilowitz NR; Toleva O; Chieffo A; Perera D; Berry C
Circ Cardiovasc Interv; 2023 Jun; 16(6):e012568. PubMed ID: 37259860
[TBL] [Abstract][Full Text] [Related]
19. Microvascular Resistance Reserve to Assess Microvascular Dysfunction in ANOCA Patients.
de Vos A; Jansen TPJ; van 't Veer M; Dimitriu-Leen A; Konst RE; Elias-Smale S; Paradies V; Rodwell L; van den Oord S; Smits P; van Royen N; Pijls N; Damman P
JACC Cardiovasc Interv; 2023 Feb; 16(4):470-481. PubMed ID: 36858668
[TBL] [Abstract][Full Text] [Related]
20. A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve.
Bairey Merz CN; Handberg EM; Shufelt CL; Mehta PK; Minissian MB; Wei J; Thomson LE; Berman DS; Shaw LJ; Petersen JW; Brown GH; Anderson RD; Shuster JJ; Cook-Wiens G; Rogatko A; Pepine CJ
Eur Heart J; 2016 May; 37(19):1504-13. PubMed ID: 26614823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
